<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Mol. Pharmacol</journal-id><journal-id journal-id-type="pmc-domain-id">830</journal-id><journal-id journal-id-type="pmc-domain">molpharm</journal-id><journal-id journal-id-type="publisher-id">MolPharm</journal-id><journal-title-group><journal-title>Molecular Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0026-895X</issn><issn pub-type="epub">1521-0111</issn><publisher><publisher-name>American Society for Pharmacology and Experimental Therapeutics</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC4366799</article-id><article-id pub-id-type="pmcid-ver">PMC4366799.1</article-id><article-id pub-id-type="pmcaid">4366799</article-id><article-id pub-id-type="pmcaiid">4366799</article-id><article-id pub-id-type="pmid">25583085</article-id><article-id pub-id-type="doi">10.1124/mol.114.096701</article-id><article-id pub-id-type="publisher-id">MOL_096701</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Rapid Throughput Analysis Demonstrates that Chemicals with Distinct Seizurogenic Mechanisms Differentially Alter Ca<sup>2+</sup> Dynamics in Networks Formed by Hippocampal Neurons in Culture</article-title><alt-title alt-title-type="short">Rapid Throughput SCO Analysis of Seizurogenic Agents</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Cao</surname><given-names initials="Z">Zhengyu</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zou</surname><given-names initials="X">Xiaohan</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cui</surname><given-names initials="Y">Yanjun</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hulsizer</surname><given-names initials="S">Susan</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lein</surname><given-names initials="PJ">Pamela J.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wulff</surname><given-names initials="H">Heike</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Pessah</surname><given-names initials="IN">Isaac N.</given-names></name></contrib><aff id="aff1">State Key Laboratory of Natural Medicines and Jiangsu Provincial Key laboratory for TCM Evaluation and Translational Development, China Pharmaceutical University, Nanjing, P.R. China (Z.C., X.Z., Y.C.); Department of Molecular Biosciences, School of Veterinary Medicine (Z.C., Y.C., S.H., P.J.L., I.N.P.) and Department of Pharmacology, School of Medicine (H.W.),University of California, Davis, California</aff></contrib-group><author-notes><corresp id="cor1"><bold>Address correspondence to:</bold> Isaac N. Pessah, <addr-line>Department of Molecular Biosciences, School of Veterinary Medicine, 1089 Veterinary Medicine Drive, University of California, Davis, One Shields Avenue, Davis, CA 95616.</addr-line> E-mail: <email>inpessah@ucdavis.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>4</month><year>2015</year></pub-date><pub-date pub-type="epub"><month>4</month><year>2015</year></pub-date><volume>87</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">250787</issue-id><fpage>595</fpage><lpage>605</lpage><history><date date-type="received"><day>10</day><month>11</month><year>2014</year></date><date date-type="accepted"><day>12</day><month>1</month><year>2015</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2016</year></date></event><event event-type="pmc-live"><date><day>01</day><month>04</month><year>2016</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-07-07 02:25:10.207"><day>07</day><month>07</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2015 by The American Society for Pharmacology and Experimental Therapeutics</copyright-statement><copyright-year>2015</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="mol.114.096701.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="mol.114.096701.pdf"/><abstract><p>Primary cultured hippocampal neurons (HN) form functional networks displaying synchronous Ca<sup>2+</sup> oscillations (SCOs) whose patterns influence plasticity. Whether chemicals with distinct seizurogenic mechanisms differentially alter SCO patterns was investigated using mouse HN loaded with the Ca<sup>2+</sup> indicator fluo-4-AM. Intracellular Ca<sup>2+</sup> dynamics were recorded from 96 wells simultaneously in real-time using fluorescent imaging plate reader. Although quiescent at 4 days in vitro (DIV), HN acquired distinctive SCO patterns as they matured to form extensive dendritic networks by 16 DIV. Challenge with kainate, a kainate receptor (KAR) agonist, 4-aminopyridine (4-AP), a K<sup>+</sup> channel blocker, or pilocarpine, a muscarinic acetylcholine receptor agonist, caused distinct changes in SCO dynamics. Kainate at &lt;1 <italic toggle="yes">&#181;</italic>M produced a rapid rise in baseline Ca<sup>2+</sup> (Phase I response) associated with high-frequency and low-amplitude SCOs (Phase II response), whereas SCOs were completely repressed with <underline>&gt;</underline>1 <italic toggle="yes">&#181;</italic>M kainate. KAR competitive antagonist CNQX [6-cyano-7-nitroquinoxaline-2,3-dione] (1-10 <italic toggle="yes">&#181;</italic>M) normalized Ca<sup>2+</sup> dynamics to the prekainate pattern. Pilocarpine lacked Phase I activity but caused a sevenfold prolongation of Phase II SCOs without altering either their frequency or amplitude, an effect normalized by atropine (0.3&#8211;1 <italic toggle="yes">&#181;</italic>M). 4-AP (1&#8211;30 <italic toggle="yes">&#181;</italic>M) elicited a delayed Phase I response associated with persistent high-frequency, low-amplitude SCOs, and these disturbances were mitigated by pretreatment with the K<sub>Ca</sub> activator SKA-31 [naphtho[1,2-<italic toggle="yes">d</italic>]thiazol-2-ylamine]. Consistent with its antiepileptic and neuroprotective activities, nonselective voltage-gated Na<sup>+</sup> and Ca<sup>2+</sup> channel blocker lamotrigine partially resolved kainate- and pilocarpine-induced Ca<sup>2+</sup> dysregulation. This rapid throughput approach can discriminate among distinct seizurogenic mechanisms that alter Ca<sup>2+</sup> dynamics in neuronal networks and may be useful in screening antiepileptic drug candidates.</p></abstract><counts><page-count count="11"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name> DJS Export </meta-name><meta-value>v1</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>